- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharma
InMed Pharmaceuticals Inc+ Add to Watchlist
MWG2:GR0.227 EUR 0.039 20.74%
As of 11:14:09 ET on 02/27/2015.
Company Profile for InMed Pharmaceuticals Inc (MWG2)
InMed Pharmaceuticals Inc. is a biopharmaceutical company. The Company develops cannabis-based botanical and non-botanical therapies through research and development into the extensive pharmacology of cannabinoids. InMed Pharmaceuticals focuses on its proprietary platform technology, drug discovery, and commercialization development.
InMed Pharmaceuticals Inc
Key Executives for InMed Pharmaceuticals Inc (MWG2)
|Craig D SchneiderPresident/CEO||Terese J GieselmanCFO/Secretary|